Shares in European legal publishing companies plunged Tuesday as investors reacted to newly released tools from artificial-intelligence provider Anthropic.

FLIN: Trade Deal Provides Potential Catalyst

Coterra Energy CTRA and Devon Energy DVN have formally disclosed a definitive agreement to merge through an all-stock transactionin a move that promises to reshape the landscape of the shale energy industry. This strategic merger is set to create a dominant large-cap shale operator, combining the strengths of both companies to drive substantial value and establish a strong foundation for sustained shareholder growth.

ACAD expects a negative CHMP opinion on trofinetide marketing application for Rett syndrome, likely delaying a potential EU approval.

Pfizer (PFE) came out with quarterly earnings of $0.66 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.63 per share a year ago.

RPC (RES) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.06 per share a year ago.

Rithm (RITM) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.55 per share. This compares to earnings of $0.6 per share a year ago.

Capri Holdings (CPRI) came out with quarterly earnings of $0.81 per share, beating the Zacks Consensus Estimate of $0.78 per share. This compares to earnings of $0.45 per share a year ago.

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that the financial advisors of Wealth Innovations, LLC have joined LPL Financial's broker-dealer and Registered Investment Advisor (RIA) platform. They reported serving approximately $200 million in advisory, brokerage and retirement plan assets* and join LPL from Osaic.

Recorlev drives robust top-line expansion, while Gvoke and Keveyis provide stable revenue streams in niche, high-need markets, supporting operational leverage. XP-8121, a once-weekly injectable levothyroxine, is 'Phase 3 ready' and targets a large, underserved hypothyroidism market, offering significant long-term upside. XERS trades at a conservative 4.3x forward P/S despite outpacing peers in growth and is showing improving EBITDA.

Disney's Q1 2026 earnings report was not well-received by investors and unfortunately this is only foreshadowing of what's to come in 2026. The expected double-digit earnings growth in 2026 will likely come under scrutiny as the year progresses for reasons that became apparent a couple of months ago. Additionally, Walt Disney continues to rely on sequels and remakes to fuel its theatrical release slate and that's not a viable long-term strategy.

Tesla's energy unit is surging as EV demand wobbles, with record deployments, rising gross margins near 30%, and a deep Megapack backlog driving 2026 momentum.

Fintech stocks like SoFi, Visa and Robinhood are drawing attention as AI, blockchain and digital payments reshape finance and expand access worldwide.

Josh D'Amaro, the longtime Disney executive who runs the company's global theme parks and experiences business, has been tapped as the next chief executive of The Walt Disney Company, ending Bob Iger's long and closely watched succession saga at the entertainment giant, the company announced.

The nationwide program invites eligible Natrelle® breast augmentation and reconstruction patients to share their personal experiences. Natrelle® champions women's voices to provide support at every step of their breast aesthetics journey.

ORLANDO, Fla., Feb. 3, 2026 /PRNewswire/ -- M-tron Industries, Inc. (NYSE American: MPTI) ("Mtron" or the "Company") today announced Cameron Pforr, Chief Executive Officer, and Chris Nossokoff, Vice President – Financial Reporting, will present at TD Cowen's 47th Annual Aerospace & Defense Conference on Wednesday February 11, 2026 at The Ritz-Carlton, Pentagon City, in Arlington, Virginia.

As visas, eVisas, and ETAs evolve worldwide, iVisa reports maintaining a 99% approval rate across the applications it supports. MIAMI, Feb. 03, 2026 (GLOBE NEWSWIRE) -- International travel in 2026 is being reshaped not just by rising passenger demand, but by rapidly evolving visa and travel authorization requirements.

Shares in FTSE 100 data publishers were slammed by AI worries on Tuesday after US AI company Anthropic released a new 'agentic' tool for corporate legal teams. RELX PLC, which owns legal industry information and analytics provider LexisNexis, slumped 12%; while London Stock Exchange Group PLC dropped 8.1%, and Experian PLC fell 7.4%.

Bank says latest CagriSema results meet expectations, with investor focus shifting to head-to-head data against Eli Lilly's tirzepatide. Novo Nordisk (NYSE:NVO) has reported positive headline results from a late-stage trial of its next-generation diabetes drug CagriSema, but analysts at Citi said the data were largely expected and that more consequential readouts lie ahead.

In the nearly nine months spanning from May 2025 to February 2026, Johnson & Johnson (JNJ)'s stock experienced a remarkable 52% increase, driven by improved earnings, significant product achievements, and advancements in legal matters. Behind this 3.2% uplift in revenue and enhancement in margins is a narrative of innovation, effective risk management, and strategic evolution—let's delve into what has influenced this change.